Institutional members access full text with Ovid®

Share this article on:

Can Ovarian Cancer Screening Save Lives? The Question Remains Unanswered

Jacobs, Ian MD; Menon, Usha MD

doi: 10.1097/AOG.0b013e31823b49b3
Editorials

See related article on page 1212.

Dr. Jacobs is from The University of Manchester and Department of Women's Cancer, Institute for Women's Health, University College London; e-mail: ian.jacobs@manchester.ac.uk. Dr. Menon is from the Department of Women's Cancer, Institute for Women's Health, University College London; e-mail: u.menon@ucl.ac.uk.

Financial Disclosure Dr. Jacobs is a principal investigator on the UK Collaborative Trial of Ovarian Cancer Screening and UK Familial Ovarian Cancer Screening Study, a Consultant to Becton Dickinson on biomarkers and ovarian cancer, and a Non Executive Director and shareholder with Abcodia Ltd. Dr. Menon is the co-principal investigator on the UK Collaborative Trial of Ovarian Cancer Screening and UK Familial Ovarian Cancer Screening Study and a Non Executive Director and shareholder with Abcodia Ltd. She has collaborated on research with Becton Dickinson on biomarkers and ovarian cancer.

© 2011 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.